Services · 02

Launch Excellence

The commercial trajectory of a brand is largely set in the 18 months before approval. Launch teams that arrive at day one with incomplete market access coverage, undertrained field forces, or an unclear value story rarely recover the revenue lost in the early months — and ZS research indicates that revenue lost in the first 12–24 months of a suboptimal launch is rarely fully recovered over the product lifecycle.

What we do

We work alongside launch teams to build the cross-functional infrastructure, commercial readiness, and measurement frameworks that convert a strong clinical asset into a strong commercial performance. Our work spans from early pre-launch planning through to post-launch performance optimisation.

Specific offerings

Pre-Launch Readiness Assessment

A structured diagnostic of where the brand, field organisation, and cross-functional teams stand against launch-readiness benchmarks — across market access, medical, marketing, and sales. We identify critical gaps and build a prioritised action plan to close them before day one.

Integrated Launch Planning

We facilitate and structure the end-to-end launch plan across medical, market access, marketing, and field — with aligned timelines, clear ownership, and explicit dependencies. The plan is built to survive the inevitable shifts in approval timelines and competitive dynamics.

Message Architecture & Claims Mapping

We develop the full message hierarchy from core scientific narrative to field-ready claims and payer value messages — with a clear evidence map behind each claim and an MLR-ready structure that accelerates approval and deployment.

Field Force Readiness & Training

We design the training curriculum, certification processes, and manager coaching infrastructure that puts field teams on-message, compliant, and confident at day one — not three months after.

Launch KPI Framework & Tracking

We define the leading and lagging indicators that provide early visibility into whether the launch is tracking to plan — including coverage metrics, field activity measures, and prescribing velocity signals — and build the tracking infrastructure to monitor them in real time.

First-in-Class & Rare Disease Launch

For launches where the clinical story, diagnosis pathway, market size, or payer environment is genuinely uncharted, we provide specialist support — including epidemiology-based forecasting, patient finder strategies, specialist centre engagement, and unbranded disease awareness planning.

← All services
AI-enabled capability

Early launch signal detection using prescription velocity, payer coverage data, and field activity patterns — identifying which geographies and prescriber segments are tracking below expectation within the first 90 days, enabling rapid course correction before gaps compound.

Related case study
Launch Excellence

First Product Launch: Comprehensive Commercial Infrastructure Build

Context

A emerging pharma preparing its first commercial product launch needed to build commercial infrastructure from the ground up — including master data management, analytics setup, segmentation, targeting, and field readiness — within a constrained timeline.

Approach

We led the end-to-end commercial build: establishing the MDM framework and data architecture, designing the segmentation and targeting model, structuring the launch KPI framework, and supporting field training design. Work was sequenced against regulatory milestones to ensure readiness at each stage.

Outcome

The organisation launched on time with a functioning commercial infrastructure, a trained field force, and real-time performance visibility from day one — avoiding the common first-launch pattern of building analytics capability reactively after launch.

See all case studies →

Tell us the problem

We'll tell you honestly whether and how we can help.

Start a conversation